|
| PPAR | PPAR-action | Disease | Model | Reference |
|
|
PPARγ | Reduced circulating PPARγ activators in serum from women with PE | PE | In vitro | Waite et al. [111] |
| Placental 15dPGJ2level are
decreased in diabetes | GDM | Murine | Capobianco et al. [95] |
| Association
of PPAR-γ2 Pro12Ala with
weight gain | GDM | Human | Tok et al. [112] |
| Placental 15dPGJ2levels are
decreased | GDM | Human | Javerbaum et al. [113] |
| Decreased | Hydatidiform mole | Human | Capparuccia et al. [114] |
| Decreased | Choriocarcinoma | Human | Capparuccia et al. [114] |
| Placental
PPAR expression is not involved | IUGR | Human | Rodie et al. [115] |
| Association of PPAR-γ2 Pro12Ala polymorphism | Preterm
birth | Human | Meirhaeghe et al. [116] |
|
| PPARα | Lack of PPAR-α upregulates Th1 cytokines | Abortion/neonatal mortality | Murine | Yessoufou et al. [76] |
|